Actively Recruiting
Effectiveness of the Diabetes Homeless Medication Support (D-HOMES) Program on Diabetes Management
Led by Katherine Vickery · Updated on 2025-07-29
256
Participants Needed
1
Research Sites
222 weeks
Total Duration
On this page
Sponsors
K
Katherine Vickery
Lead Sponsor
N
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this clinical trial is to learn if the Diabetes Homelessness Medication Support (D-HOMES) wellness coaching model is effective for adults who speak English or Spanish, have Type 2 diabetes with an HbA1c at or above 7.5, and have recently experienced homelessness. Researchers will compare a one-time education session about diabetes to 10 wellness coaching sessions to see if there are differences between the groups' health outcomes. The main questions it aims to answer are: * Do D-HOMES participants have greater reductions in HbA1c at 3 months than participants who received education? * Do D-HOMES participants have greater reductions in HbA1c at 6 and 12 months compared to those who received education? * Do D-HOMES participants have improvements in blood pressure control, quality of life, self-reported psychological wellness, diabetes distress, and diabetes medication adherence and self-management at 3, 6, and 12 months? * What factors must be considered to make D-HOMES scalable? Participants will: * complete 5 assessments including two baseline assessments and follow-ups at months 3,6, and 12 * participate in a one-time education session or 10 weeks of wellness coaching.
CONDITIONS
Official Title
Effectiveness of the Diabetes Homeless Medication Support (D-HOMES) Program on Diabetes Management
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- English or Spanish speaking
- Recent homelessness or housing instability as defined by HUD and HHS
- Self-reported diagnosis of Type 2 diabetes with HbA1c greater than 7.5%, verified by medical record or study lab test
- Plan to stay in local area or be reachable by phone for 12 months
- Willingness to work on medication adherence and diabetes self-care
You will not qualify if you...
- Unable to provide informed consent (such as having a legal guardian or being a prisoner)
- Active psychosis or intoxication preventing informed consent
- Pregnant or lactating at enrollment, determined by screening
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hennepin Healthcare Research Institute
Minneapolis, Minnesota, United States, 55404
Actively Recruiting
Research Team
K
Katherine D Vickery, MD, MSc
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here